Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Income from Continuing Operations (2024 - 2026)

Beta Bionics' Income from Continuing Operations history spans 3 years, with the latest figure at 21895000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 35.1% to 21895000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 66438000.0, a 34.94% decrease, with the full-year FY2025 number at 60749000.0, down 46.94% from a year prior.
  • Income from Continuing Operations hit 21895000.0 in Q1 2026 for Beta Bionics, down from 13466000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for BBNX hit a ceiling of 8314000.0 in Q1 2024 and a floor of 21895000.0 in Q1 2026.
  • Historically, Income from Continuing Operations has averaged 13776222.22 across 3 years, with a median of 13466000.0 in 2025.
  • The widest YoY moves for Income from Continuing Operations: up 11.42% in 2025, down 94.92% in 2025.
  • Tracing BBNX's Income from Continuing Operations over 3 years: stood at 12086000.0 in 2024, then fell by 11.42% to 13466000.0 in 2025, then crashed by 62.59% to 21895000.0 in 2026.
  • Business Quant data shows Income from Continuing Operations for BBNX at 21895000.0 in Q1 2026, 13466000.0 in Q4 2025, and 14210000.0 in Q3 2025.